PARD (Poniard Pharmaceuticals) Other Stockholders Equity: $-0.00 Mil (As of Sep. 2011)


What is Poniard Pharmaceuticals Other Stockholders Equity?

Poniard Pharmaceuticals PARD Other Stockholders Equity is $-0.00 Mil as of Sep. 2011.

Poniard Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Sep. 2011 was $-0.00 Mil.

Poniard Pharmaceuticals's quarterly Other Stockholders Equity declined from Mar. 2011 ($0.00 Mil) to Jun. 2011 ($-0.00 Mil) but then increased from Jun. 2011 ($-0.00 Mil) to Sep. 2011 ($-0.00 Mil).

Poniard Pharmaceuticals's annual Other Stockholders Equity increased from Dec. 2008 ($-0.00 Mil) to Dec. 2009 ($-0.00 Mil) but then declined from Dec. 2009 ($-0.00 Mil) to Dec. 2010 ($-0.00 Mil).

Poniard Pharmaceuticals Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Other Stockholders Equity Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 -0.00

Poniard Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Poniard Pharmaceuticals (PARD) has a Other Stockholders Equity of $-0.00 Mil as of Sep. 2011. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Other Stockholders Equity too high?
Poniard Pharmaceuticals' current Other Stockholders Equity is $-0.00 Mil.
How does Poniard Pharmaceuticals' Other Stockholders Equity compare to OBMP and NSPX?
Poniard Pharmaceuticals' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Other Stockholders Equity is $-0.00 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.